The Importance of Medication Reconciliation in a Patient with Parkinson’s Disease

In this case, a 67-year-old male experienced a progression of his Parkinson's disease symptoms following an inpatient hospitalization for pneumonia. He presents to the neurology clinic for follow-up, where the neurology ambulatory care pharmacist was consulted to assist with his case. The pharmacist identified a medication reconciliation discrepancy that resulted in an unintentional change in the dosing frequency of his carbidopa/levodopa. This, combined with the initiation of metoclopramide, a dopamine-receptor antagonist, led to a worsening of his Parkinson's symptoms. His carbidopa/levodopa dose was titrated back to the previous regimen, metoclopramide was discontinued, and his symptoms significantly improved. This case highlights the importance of best practices in medication reconciliation for patients with Parkinson's disease, the impact of drug-disease interactions, and emphasizes the critical role of ambulatory care pharmacists in geriatric patient care.

Authors

Institutions

Publication Details

Journal
The Senior Care Pharmacist
Published
2025-11-01
DOI
https://doi.org/10.4140/tcp.n.2025.443
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Importance of Medication Reconciliation in a Patient with Parkinson’s Disease

Sarah Steely Wright, Charlie Wright
The Senior Care Pharmacist
Pharmaceutical Practices and Patient Outcomes
article

The Importance of Medication Reconciliation in a Patient with Parkinson’s Disease

Sarah Steely Wright, Charlie Wright
article en

Abstract

In this case, a 67-year-old male experienced a progression of his Parkinson's disease symptoms following an inpatient hospitalization for pneumonia. He presents to the neurology clinic for follow-up, where the neurology ambulatory care pharmacist was consulted to assist with his case. The pharmacist identified a medication reconciliation discrepancy that resulted in an unintentional change in the dosing frequency of his carbidopa/levodopa. This, combined with the initiation of metoclopramide, a dopamine-receptor antagonist, led to a worsening of his Parkinson's symptoms. His carbidopa/levodopa dose was titrated back to the previous regimen, metoclopramide was discontinued, and his symptoms significantly improved. This case highlights the importance of best practices in medication reconciliation for patients with Parkinson's disease, the impact of drug-disease interactions, and emphasizes the critical role of ambulatory care pharmacists in geriatric patient care.

The Senior Care PharmacistVol. 40(11)
Harding University Main Campus (US), University of Arkansas Medical Center (US), Pulaski Technical College (US), Arkansas Department of Health (US)
Openalex Percentile: Top 59%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Importance of Medication Reconciliation in a Patient with Parkinson’s Disease — Sarah Steely Wright, Charlie Wright · The Senior Care Pharmacist (2025) | TGRS Research Map | TGRS